Term Sheet Decoded: Key Clauses Every Founder Must Understand Before Signing

Term Sheet Decoded: Key Clauses Every Founder Must Understand Before Signing

There's a moment every founder talks about — the one where an investor finally says, "We're interested. Let me send you the term sheet."

It feels like the finish line. It's actually the starting gun.

A term sheet lands in your inbox as a 57 page document. It looks manageable. It reads politely. The investor has been warm through all your pitch meetings. You're tempted to skim it, celebrate, and sign.

Don't.

That document — those few pages — will quietly decide whether you walk away from your company's exit with a crore or ten. Whether you can be outvoted on your own company's decisions. Whether your cofounder can be forced out a month before the Series B. Whether the investor gets paid first, last, or everything, when the company sells.

Founders in India have lost control of their startups — not at acquisition, not at the final contract signing — but right here, at this stage, because they treated a term sheet like a formality.

This piece is not a glossary. There are enough of those. This is about what each clause actually does to you, your equity, and your ability to run your company. Let's go through it.

First, What Exactly Is a Term Sheet?

A term sheet is a preinvestment document. It captures the headline commercial understanding between you and the investor before lawyers start drafting the actual contracts — the Share Subscription Agreement (SSA) and the Shareholders' Agreement (SHA).

Here's what most founders misunderstand about it: a term sheet is described as "nonbinding," which sounds like it means nothing is settled. That's misleading.

Yes, the commercial terms — valuation, equity, rights — are technically nonbinding until the SHA and SSA are signed. But in practice, by the time your lawyers sit down to draft those documents, both sides have already told their teams the deal is done. Reopening valuation or liquidation preference at that stage is treated as bad faith. Investors have seen that move before, and they do not like it.

What you agreed to in principle in the term sheet is, in almost every case, what you will live with for the next five to seven years.

The clauses that are legally binding from the moment you sign? Confidentiality, exclusivity (noshop), and costs. That means the moment you sign a term sheet, you usually cannot go talk to other investors for a fixed window — typically 30 to 60 days — and you may be on the hook for legal costs if the deal falls apart.

A Delhibased startup had to dissolve after breaching a noshop clause founders barely remembered agreeing to. A Bengaluru founder was sued for "bad faith" after signing two term sheets with overlapping clauses. These are not cautionary tales from a textbook. They happened.

The Clauses That Actually Matter

1. Valuation: PreMoney vs. PostMoney (This Is Not the Same Number)

The investor offers you ?5 crore at a ?20 crore premoney valuation. Great. So postinvestment, the company is worth ?25 crore, and they own 20%.

But here's where things go wrong for a lot of firsttime founders: the ESOP pool.

Investors commonly ask that an employee stock option pool — typically 10% to 15% of the company — be created before the investment is calculated. This is called the "option pool shuffle," and it is one of the most quietly painful clauses in a term sheet.

Say the investor wants a 15% ESOP pool created premoney. You started with 100% equity. Now 15% gets carved out before the investment math even begins. So the investor's 20% stake is calculated on the postESOP, premoney base. Your actual dilution is significantly higher than what the headline valuation suggests.

The fix: always negotiate to create or expand the ESOP pool postmoney. The difference is not cosmetic — it directly affects how much of your company you actually own after the round closes.

2. Liquidation Preference: Who Gets Paid First When the Company Sells

This is the single most consequential clause for founders — and the most frequently underestimated.

When a company is acquired, there's a defined order in which money gets distributed. Liquidation preference determines where the investor stands in that queue.

1x nonparticipating preference — This is the market standard and the founderfriendly version. The investor gets their money back first (1x what they put in). After that, any remaining proceeds are distributed among all shareholders based on equity ownership. So if an investor put in ?8 crore and the company sells for ?50 crore, they take ?8 crore first, and the rest is split proportionally.

Participating preferred — This is the version founders should push back on. Here, the investor gets their 1x first and then continues to participate in the remaining proceeds as if they converted to equity. They get paid twice, essentially.

Here's the math to make this real: Suppose an investor put in ?8 crore for a 20% stake, and you exit at ?15 crore.

• With 1x nonparticipating, the investor takes ?8 crore, founders and others split the remaining ?7 crore.
• With participating preferred, the investor takes ?8 crore first, then gets 20% of the remaining ?7 crore on top — about ?1.4 crore more. You just lost another ?1.4 crore sitting across from someone at a handshake dinner.

Watch for multipliers too. A 2x or 3x liquidation preference — where the investor gets two or three times their investment before anyone else gets a rupee — was common in older Indian VC deals. The market has moved toward 1x, but you will still encounter higher multiples in competitive or distressed deals.

3. AntiDilution: What Happens If the Next Round Is at a Lower Valuation

You raised your seed round at a ?30 crore valuation. Then things slow down, and your Series A comes in at ?20 crore. This is called a down round — and it triggers antidilution protection for investors who have this clause in their term sheet.

Antidilution works by adjusting the price at which the investor's preference shares convert into equity. Essentially, they get more shares than originally agreed to compensate for the fact that the company is now worth less.

There are two main types:

Full ratchet — The investor's conversion price drops to match the new, lower round price. This is brutal for founders. If they bought shares at ?100 and the next round prices shares at ?50, they effectively get double the equity. Your stake gets hammered.

Broadbased weighted average — This is the standard and more reasonable version. The conversion price adjustment is calculated based on how many new shares are issued and at what price, so the dilution is spread more evenly. It still hurts founders in a down round, but not catastrophically.

One important update as of April 2025: the Finance Act 2024 abolished angel tax (Section 56(2)(viib) of the Income Tax Act). CCPS — Compulsorily Convertible Preference Shares, the most common instrument in Indian VC deals — can now be issued at a premium above fair market value without triggering a tax liability at the company level. This removes a significant friction from earlystage fundraising that founders previously had to plan around.

4. Board Composition: Who Actually Controls Decisions

The term sheet will specify who gets seats on the board. A typical earlystage deal might give an investor one board seat. Sounds reasonable.

But add it up. If the company has a fiveperson board — two founders, one investor, one independent, one reserved for a future investor — and the investor controls the nomination of the independent director, they effectively have two votes in five. One protective provision veto right later, and the founders are in a minority on major decisions.

Watch for protective provisions in this section. These are a list of decisions the company cannot take without investor consent — things like issuing new shares, taking on debt above a threshold, changing the business model, or approving acquisitions. A long and broad list of protective provisions can make it nearly impossible to operate without approval from someone who is not running the business.

Since 2022, following governance failures at several highprofile Indian startups, investors have dramatically expanded their standard governance package. Mandatory appointment of an independent CFO acceptable to the investor, stricter information rights, and expanded audit provisions are now nearstandard at institutional seed and Series A rounds. If you're raising from a serious investor, expect these conversations.

5. Founder Vesting: Yes, You Also Get Vested

Many founders are caught off guard when they realize their own shares will be subject to a vesting schedule. You built the company. You hold 50%. But if you leave in year one, under a vesting clause, you may not be able to keep those shares.

The standard structure in India is a fouryear vesting schedule with a oneyear cliff. This means:

• If a founder leaves before completing one year, they lose all unvested shares.
• After the oneyear cliff, shares vest monthly or quarterly over the remaining three years.

For firsttime founders raising institutional capital, there's often an additional complication: revesting. If you've been running the company for two years before your first investment, the investor may insist that your entire shareholding revests from the date of investment — not from your founding date. This is negotiable, but it catches founders by surprise regularly.

There is also the concept of good leaver vs. bad leaver. A "good leaver" (someone who leaves due to death, disability, or mutual agreement) typically keeps a portion of their shares. A "bad leaver" (someone who quits, breaches their obligations, or gets pushed out for cause) may forfeit shares entirely or be forced to sell at a punitive price.

Investorside "bad leaver" definitions have expanded considerably in India since 2022. What was once limited to fraud or wilful misconduct now regularly includes criminal complaints, breach of noncompete obligations, and in some term sheets, even vaguely defined "reputational events." Scrutinize this definition. A loose bad leaver clause can be weaponized.

6. DragAlong and TagAlong Rights

These two clauses sound similar but protect opposite parties.

Dragalong: If a majority shareholder — often the investor, or a coalition — decides to sell the company, they can force minority shareholders (including other founders) to sell their shares on the same terms. This prevents a small group from blocking an acquisition.

From the investor's perspective, dragalong is essential. From a founder's perspective, it means that if your investor wants to exit at a price you think is too low, they may be able to compel you to sell.

Tagalong: If a majority shareholder sells their stake, minority shareholders have the right to "tag along" and sell their shares on the same terms. This protects founders from a scenario where an investor sells to a third party who then effectively controls the company without you having an exit option.

Both clauses can be reasonable in wellnegotiated deals. The red flags are in the details: What percentage constitutes a "majority" that can trigger dragalong? What happens if founders disagree with the exit price? Is there a minimum valuation floor below which dragalong cannot be triggered?

7. NoShop / Exclusivity: The Clock Starts Now

Once you sign a term sheet, the noshop clause kicks in. For a defined period — usually 30 to 60 days — you agree not to solicit or negotiate with other investors.

This is binding. Violating it can expose you to legal consequences, and in some cases, the investor can claim damages or even sue for loss of opportunity.

A few things to negotiate here: the length of the exclusivity window (keep it short — 30 days with an optional 15day extension is reasonable), whether the extension is automatic or requires mutual consent, and what happens if the investor themselves cause delays in due diligence. Some term sheets have an automatic exclusivity renewal provision if closing delays are attributed to the company — even if those delays arise from undefined milestones the investor set. This is a trap.

8. Information Rights: What You're Required to Share

The investor will ask for regular financial reporting — monthly MIS, quarterly financials, annual audited accounts. Some will ask for board observer rights, which allow their representative to attend board meetings without voting rights.

These are generally standard and reasonable. Where founders get into trouble is when information rights are combined with approval rights. For example, if the investor has both a right to monthly MIS and a protective provision requiring investor consent before any expense above a threshold — now you're effectively operating with a coCFO who doesn't work for you.

Also watch for "inspection rights" — the right to physically inspect the company's books and records. Combined with expanded governance clauses, a motivated investor can make your life extremely difficult through information demands during a dispute.

The Zostel–OYO Warning Every Founder Should Know

In the Zostel vs. OYO arbitration, an Indian court held that a term sheet — which both parties had treated as nonbinding — created enforceable obligations because the conduct of the parties after signing demonstrated reliance on it.

This case changed how Indian law looks at "nonbinding" term sheets. The takeaway is direct: if you act like a term sheet is binding — and in practice, most founders do — courts may hold you to it even where the document says it is not.

This is especially relevant for Indian startups that move fast, close deals informally, and assume that a document described as "nonbinding" is just a formality until the lawyers are done. It is not.

What Changes After 2022: The New Governance Reality

The governance failures at several wellknown Indian startups between 2021 and 2024 — fund diversion, undisclosed liabilities, manipulated financials — shifted the VC negotiating dynamic considerably. Investors who previously relied on founder trust now build legal protections into every deal.

What has become nearstandard in institutional Indian term sheets today that wasn't before:

• Mandatory independent CFO appointment, subject to investor approval
• Expanded bad leaver definitions covering breach of noncompetes and regulatory violations
• Mandatory forensic audit rights if a governance concern is raised
• Personal guarantees or indemnities from founders in certain cases
• Antibribery representations and compliance certifications

This doesn't mean the investor is your adversary. It means the ecosystem has matured — and so should your understanding of what you're agreeing to.

Before You Sign: A Practical Checklist

Run through these before you put your signature on anything:

On valuation and dilution:

• What is my actual postmoney ownership percentage after accounting for the ESOP pool?
• Is the ESOP pool being created premoney or postmoney?
• Have I modeled a scenario where I raise the next round at a lower valuation — what does my antidilution clause do to my equity?

On economics:

• Is the liquidation preference 1x nonparticipating? If not, why, and what is the investor's justification?
• Is there a participation cap (e.g., 2x or 3x) if participating preferred is insisted upon?
• Who else has liquidation preference, and in what order?

On control:

• Who controls board composition? Who nominates the independent director?
• What is on the list of protective provisions? Is the list proportionate or does it cover routine business decisions?
• Under what conditions can I be removed as CEO?

On founder protection:

• What is the vesting schedule? Does my existing shareholding revest?
• How is "bad leaver" defined? Is it narrow and specific, or broad and vague?
• Is there acceleration on acquisition — single trigger or double trigger?

On exit:

• What triggers the dragalong? What is the minimum valuation floor?
• What are the tagalong provisions if the investor exits before I do?
• Are there any right of first refusal clauses that could make my shares illiquid?

On binding commitments:

• How long is the noshop period? Under what conditions does it extend?
• What are the confidentiality obligations, and how long do they run?
• Who pays legal fees if the deal doesn't close — and under what conditions?

A Note on Getting Help

A term sheet is not a document to handle alone. An experienced CA or startup lawyer familiar with Indian funding deals will catch things that a firsttime founder will not — not because the founder is careless, but because the language is deliberately designed to read simply while carrying significant implications.

At our firm, we regularly work with founders raising their first or second round of funding. We see the same surprises repeatedly — founders who didn't model the ESOP dilution, cofounders who didn't realize their revesting clause reset their equity clock, promoters who signed an exclusivity window that was longer than their runway.

The money in the term sheet is visible. The terms that accompany it are invisible until they aren't.

Closing Thought

The Indian startup ecosystem has grown up. The investors are more sophisticated, the deal terms are more complex, and the consequences of a poorly negotiated term sheet are longerlasting than they were a decade ago.

But the fundamentals haven't changed. Read everything. Model the scenarios. Negotiate hard where it matters — liquidation preference, ESOP timing, board composition, and bad leaver definitions. Give ground on things that protect both sides. And get someone on your side who has sat across this table before.

The term sheet is not the end of fundraising. It is the beginning of a longterm relationship with an investor who will be on your cap table for years. Start that relationship by knowing exactly what you agreed to.

Have questions about your term sheet or upcoming fundraise? Our team works with startups, MSMEs, and founders at every stage on funding documentation, compliance, and tax structuring. Reach out to us at CA Dhiraj Ostwal & Associates.